Comparison of the New Algorithm of STOP-Bang in the Detection of Severe OSA Patients
NCT ID: NCT03172806
Last Updated: 2018-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
293 participants
OBSERVATIONAL
2016-08-01
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of Optimal Cutoff Value for Screening Severe Hypoxemic OSA (Obstructive Sleep Apnea) Patients
NCT03047941
Comparison of Preoperative Screening Score for Obstructive Sleep Apnea (OSA)
NCT02051829
Evaluating Accuracy of Breath Sound Recordings and STOP-Bang Screening For Obstructive Sleep Apnea While Awake
NCT02987283
Comparison of Different Screening Score for Hypoxemic OSA (Obstructive Sleep Apnea) With the Results of a Polysomnography (PSG)
NCT02050685
Inter Scorers Agreement for OSA Screening Scores.
NCT03570580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
STOP-Bang has been proposed to detect OSA patients. It has been validated. New algorithm of STOP-Bang was proposed by the end of 2016. This aim of this study was to evaluate the ability of this new algorithm to detect severe OSA patients (patients with more than 30 events per hour). The new algorithm was also compared in this same ability with three others clinical score (P-SAP, OSA50 and DES-OSA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group
All patients included in the study. First: clinical scores were collected in all patients. Second: all patients underwent a polysomnography in order to compare this results with these of the clinical scores.
Polysomnography
To compare the ability of the clinical scores, all patients included in this study underwent a polysomnography.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polysomnography
To compare the ability of the clinical scores, all patients included in this study underwent a polysomnography.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric DEFLANDRE, MD, FCCP
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric DEFLANDRE, MD, FCCP
Role: PRINCIPAL_INVESTIGATOR
Astes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Saint-Luc de Bouge
Bouge, Namur, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NASB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.